NINE MONTHS RESULTS
Alembic Pharmaceuticals Ltd.
BSE
Jun 02, 04:01
994.95
-22.25 ( -2.19%)
Volume
7347
Prev. Close
1017.20
Open Price
1017.40
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 02, 03:49
996.00
-22.05 ( -2.17%)
Volume
70556
Prev. Close
1018.05
Open Price
1010.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
996.00 (84)
You can view the
Nine Months Results
for the last 5 years.
|
ISIN No
|
INE901L01018
|
Market Cap. ( ₹ in Cr. )
|
19577.69
|
P/BV
|
4.01
|
Book Value ( ₹ )
|
248.68
|
|
BSE Code
|
533573
|
52 Week High/Low ( ₹ )
|
1304/725
|
FV/ML
|
2/1
|
P/E(X)
|
33.56
|
|
NSE Code
|
APLLTDEQ
|
Book Closure
|
15/07/2024
|
EPS ( ₹ )
|
29.68
|
Div Yield (%)
|
1.10
|
(₹ in Crs.)
| Net Sales/Income from operations | 4461.99 | 4399.51 | 3841.88 | 3692.29 | 3894.21 |
| Total Income From Operations | 4461.99 | 4399.51 | 3841.88 | 3692.29 | 3894.21 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 1245.97 | 1065.64 | 936.74 | 807.71 | 905.14 |
| Purchase of Traded Goods | 295.60 | 340.50 | 261.23 | 257.72 | 208.32 |
| Increase/Decrease in Stocks | -302.60 | -27.11 | 28.81 | 40.60 | -117.39 |
| Employees Cost | 1093.31 | 980.99 | 797.41 | 781.61 | 736.26 |
| Depreciation | 208.49 | 202.02 | 199.41 | 133.36 | 110.76 |
| Other Expenses | 1398.97 | 1329.16 | 1322.55 | 1007.98 | 910.63 |
| Total Expenses | 3939.74 | 3891.20 | 3546.15 | 3028.98 | 2753.72 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 522.25 | 508.31 | 295.73 | 663.31 | 1140.49 |
| Other Income | 34.67 | 24.10 | 1.59 | 4.86 | 5.70 |
| P/L Before Interest, Excpt. Items & Tax | 556.92 | 532.41 | 297.32 | 668.17 | 1146.19 |
| Interest | 52.76 | 44.34 | 35.40 | 10.75 | 10.63 |
| P/L Before Exceptional Items & Tax | 504.16 | 488.07 | 261.92 | 657.42 | 1135.56 |
| Exceptional Items | 12.87 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/L Before Tax | 517.03 | 488.07 | 261.92 | 657.42 | 1135.56 |
| Tax | 89.25 | 23.46 | 45.74 | 114.79 | 191.28 |
| P/L After Tax from Ordinary Activities | 427.78 | 464.61 | 216.18 | 542.63 | 944.28 |
| Net Profit/Loss For the Period | 427.78 | 464.61 | 216.18 | 542.63 | 944.28 |
| | | | | | |
| Equity Share Capital | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 21.76 | 23.64 | 11.00 | 27.61 | 39.31 |
| Diluted EPS (Rs.) | 21.76 | 23.64 | 11.00 | 27.61 | 39.31 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 21.76 | 23.64 | 11.00 | 27.61 | 39.31 |
| Diluted EPS (Rs.) | 21.76 | 23.64 | 11.00 | 27.61 | 39.31 |
| | | | | | |
| PBITOE Margin (%) | 11.70 | 11.55 | 7.69 | 17.96 | 29.28 |
| PBTE Margin (%) | 11.29 | 11.09 | 6.81 | 17.80 | 29.16 |
| PBT Margin (%) | 11.58 | 11.09 | 6.81 | 17.80 | 29.16 |
| PAT Margin (%) | 9.58 | 10.56 | 5.62 | 14.69 | 24.24 |